Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. lifeomega

LIFEOMEGA

Innovative highly concentrated Omega 3 food supplement

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 LIFEOMEGA project word cloud

Explore the words cloud of the LIFEOMEGA project. It provides you a very rough idea of what is the project "LIFEOMEGA" about.

fewer    permits    receiving    tgs    musculature    soup    quality    multiple    liquids    cachexia    nutritional    innovation    bottle    constitute    economical    utilized    psoriasis    chronic    mentioned    nutrition    requirement    treatment    dilution    fats    maximum    permit    helps    liquid    normally    15    germany    commercialization    epa    life    juice    joints    plan    solution    consists    dosages    minimizing    diseases    inflammatory    constituted    emulsion    cancer    france    maintaining    sclerosis    emulsions    arthritis    people    retinal    gr    concentration    ml    feasibility    usa    competition    supports    ip    market    spain    lifeomega    acids    asthma    chemotherapy    11    cover    necks    weight    protecting    meeting    cosmetic    anorexia    acid    fatty    pharma    ideal    search    clinical    regulatory    grams    won    supplement    unfortunately    suffer    saturated    sachet    patients    omega    athletes    italy    form    business    milk    extra    risk    consisting    food    uk    pro    cardiovascular    dietary    concentrated    reduce    million    innovative   

Project "LIFEOMEGA" data sheet

The following table provides information about the project.

Coordinator		 SOLUTEX GC SL 

Organization address
address: CTR DE BARAJAS 24 3-4 PARQUE EMPRESARIAL OMEGA EDIFICIO GAMMA
city: ALCOBENDAS MADRID
postcode: 28108
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Spain [ES]
 Project website http://www.solutex.es
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.3.2. (SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SOLUTEX GC SL ES (ALCOBENDAS MADRID) coordinator 50˙000.00

Map

 Project objective

The project aims to develop an innovative food supplement consisting on a high concentrated emulsion of Omega-3 fatty acid EPA. Omega-3 is utilized as a treatment in psoriasis, arthritis, asthma, multiple sclerosis, chronic inflammatory, cancer, high TGs, retinal diseases and cardiovascular failure.

It consists of 15 ml liquid concentration of EPA, minimizing the level of saturated fats. It’s high concentrated -3 grams EPA/ sachet–, so it allows meeting the nutritional requirements in fewer dosages. Similar products in the market are constituted of maximum 1 gr. EPA, in which a higher concentration means higher level of saturated fats. Liquid form permits the dilution in other liquids, as milk, soup, or juice.

These features permit the following applications: 1) Clinical nutrition: most of cancer patients suffer cachexia or anorexia. EPA supports weight management, reduce the pro-inflammatory response and improve quality of life.

2) Dietary supplement: EPA helps maintaining the musculature and protecting the joints, so it is ideal for competition athletes.

Innovation is present in all aspects: application, as the multiple emulsions technology is applied to food products – normally it is applied in cosmetic or pharma-; product, as there are no products in the market offering such a high EPA concentration in liquid form minimizing the saturated fats; design, as it has liquid form; and solution, as the mentioned features constitute a solution for people having an extra requirement of fatty acids.

Goal in phase I is to develop a feasibility study, including a business plan which will cover all aspects of commercialization of LIFEOMEGA: technical, economical, risk assessment, IP, regulatory, bottle necks, market study, partner search, among others.

LIFEOMEGA has a great potential, as it is estimated that cancer patients receiving chemotherapy unfortunately won’t be less than 1 million/year during the next 11 years, in USA, Spain, France, Germany, UK and Italy.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIFEOMEGA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIFEOMEGA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.3.2.)

PlotLab (2015)

PlotLab - Plot combines with integrated lab equipment for lean breading

Read More  

SubCage (2015)

Submersible Tension Leg Fish Cage for Mariculture in Unsheltered and Offshore Areas

Read More  

PROTECTDAIRY-F2F (2015)

Eco-innovative and fully integrated microbial rapid monitoring system - PROTECTING shelf life, food safety and quality throughout the DAIRY supply chain, from farm to fork.

Read More